Cat No.
CEI-1109
Description
SNS-032.HCL is a novel cyclin-dependent kinase inhibitor, which exhibits potent and selective inhibitory activity against Cdk2, Cdk7, and Cdk9. It effectively kills chronic lymphocytic leukemia cells in vitro regardless of prognostic indicators and treatment.
Abbr
SNS-032(CDK2)
Alias
p33(CDK2)
Synonyms
p33(CDK2)
CAS No.
345627-90-9
Product_Overview
cyclin-dependent kinase inhibitor
Targets
CDK2, CDK7, CDK9
Chemical Name
N-(5-((5-tert-butyloxazol-2-yl)methylthio)thiazol-2-yl)piperidine-4-carboxamide hydrochloride
M.Wt
416.99
Purity
> 95%
Solubility
DMSO > 112mg/mL Water >1mg/mL Ethanol > 4mg/mL
Storage
4 centigrade
Stability
2 years -20 centigrade Powder
1 month -4 centigrade in DMSO
More than one month -80 centigrade in DMSO
